��ɫ��

��ɫ��

Donate To Research Join The AAN

Events

Resources For

Abstract Details

Title Disability in the first 10 years of Relapse-onset MS is principally a product of relapses with incomplete recovery

Topic Multiple Sclerosis

Presentation(s) P4 - (-)

Poster/Presentation
Number 399

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Wisam Elmalik, MD (DENT Neurological institute) PRESENTER	No disclosure on file
Thomas F. Scott, MD (AHN Neurology)	Dr. Scott has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme-Sanofi. Dr. Scott has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Serono. Dr. Scott has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Scott has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Scott has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genzyme.
Edward J. Gettings, DO (Temple University)	Dr. Gettings has nothing to disclose.
Chris Hackett, MA	Mr. Hackett has nothing to disclose.
	No disclosure on file